Check out our latest official news!
Paragon announces its second GMP manufacturing facility and the expansion of its strategic collaboration in manufacturing design and operation with gene therapy leader Sarepta Therapeutics
With the Catalent transaction anticipated to close in 2Q 2019, the combined strengths of each organization will assure best manufacturing assets and unmatched operational excellence in one of the fastest-growing areas of healthcare BALTIMORE, MD, April 15, 2019 –...
Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare, positioning Catalent for accelerated long-term growthSOMERSET, N.J. and BALTIMORE, M.D. – April 15, 2019 – Catalent, Inc. (NYSE: CTLT), the leading global diversified...
Paragon Bioservices Celebrates Grand Opening of its World-Class Gene Therapy Biomanufacturing Facility
Maryland Governor Larry Hogan, Maryland Secretary of Commerce Kelly Schulz and Regional Biotech Industry Leaders Gather for Unveiling of Paragon's State-of-the-Art 200,000-square-foot CDMO Facility BALTIMORE, MD, April 11, 2019 – Paragon Bioservices, the leading...
JOIN THE CONVERSATION
Media Contacts for Media & Press:
Colleen Floreck, Senior Director, Marketing & Communications
Follow us on social media!
Paragon Bioservices will be attending and or exhibiting at the following events.
Paragon Bioservices will be attending and or be exhibiting at the following events.